A vision of the future with C-Further
Article
Tue Oct 08 2024
5 min read
David Jenkinson, Head of Childhood Cancer at LifeArc discusses C-Further's vision to drive impact for patients.
In this interview, David Jenkinson, Head of Childhood Cancer at LifeArc, discusses how C-Further is set to transform promising science into real drug candidates to treat children’s and young people’s cancer, and how convening the right people and organisations is essential in achieving this goal.
For companies which are set up to make a return on investment, then there's a challenge between doing what everyone knows is the right thing to do – to bring drugs for childhood cancer forward – versus the requirement to make that financial return.
David Jenkinson
Head of Childhood Cancer, LifeArc